Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports
Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of price negotiations, Bloomberg News reported on Tuesday citing a company executive.
If these cuts continue, as Medicare has proposed for 2025, we can expect to see additional agency closures and broader ...
As September approaches, Medicare beneficiaries should be on high alert for their Annual Notice of Change (ANOC). This year, ...
Wondering why you need Medicare if you have lifetime health insurance coverage under the Federal Employees Health Benefits ...
Social Security COLA is estimated to be around 2.5%. For many retirees, rising costs of Medicare premiums could offset much ...
Unlike other Medicare providers, physicians do not receive inflation adjustments under the Medicare Physician Fee Schedule.
Navigating Medicare can be a complex task for retirees, and accountants play a crucial role in guiding their clients through ...
Original Medicare does not cover routine dental treatments such as root canals. However, some Medicare Advantage plans ...
It is no surprise that Medicare patients often wait weeks to months for an appointment with a new provider.
President Joe Biden and Vice President Kamala Harris have repeatedly touted on the campaign trail their efforts to lower drug ...
When it comes to financing, measuring, and coordinating supplemental Medicare benefits, there are significant challenges to ...
Medicare will undergo some of the most significant changes in a generation. Changes to Medicare will include a $2,000 limit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback